Bambusa Therapeutics Prices Upsized IPO

Bambusa Therapeutics priced an upsized IPO of 10,555,555 shares at $16, for expected gross proceeds of $168.9M. Shares are expected to begin trading Oct. 30, 2026, on Nasdaq under BBTX; underwriters have a 30-day option for up to 1,583,333 shares.Material DetailsContext by AI AnalystThis is the com…